Cite
HARVARD Citation
Jansen, Y. et al. (n.d.). 3328 A randomized controlled phase II clinical trial on autologous monocyte-derived mRNA electroporated dendritic cells for stage III/IV melanoma patients who are disease-free following the local treatment of macrometastases. European journal of cancer. pp. S673-. [Online].